Senores Pharmaceuticals Limited reports a change in its board or management
In short
Senores Pharmaceuticals Limited informed the Exchange that Mr. Swapnil Jatinbhai Shah will be re-appointed as Managing Director with effect from October 15, 2026. No figures were given in the filing. In simple terms, the company is keeping the same top executive in place to run its business. The re-appointment takes effect from October 15, 2026.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.